Elisabeth Löwdin
About
Elisabeth Löwdin is a scholar working on Pharmacology, Molecular Medicine and Epidemiology.
According to data from OpenAlex, Elisabeth Löwdin has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmacology, 21 papers in Molecular Medicine and 15 papers in Epidemiology. Recurrent topics in Elisabeth Löwdin's work include Antibiotics Pharmacokinetics and Efficacy (27 papers), Antibiotic Resistance in Bacteria (21 papers) and Pneumonia and Respiratory Infections (12 papers). Elisabeth Löwdin is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (27 papers), Antibiotic Resistance in Bacteria (21 papers) and Pneumonia and Respiratory Infections (12 papers). Elisabeth Löwdin collaborates with scholars based in Sweden, Italy and Switzerland. Elisabeth Löwdin's co-authors include Otto Cars, Inga Odenholt, Thomas Tängdén, Inga Odenholt-Tornqvist, Åsa Melhus, Stellan Bengtsson, Elisabet I. Nielsen, Ingegerd Gustafsson, Marie Sandström and Anders Viberg and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.
In The Last Decade
Elisabeth Löwdin
34 papers receiving 1.2k citations
Peers
Elisabeth Löwdin
Karen E. Bowker United Kingdom
Marie-Dominique Kitzis France
Ronald N. Jones United States
Wenchi Shang United States
Michael Kresken Germany
Jane E. Ambler United States
C J Soussy France
Chris M. Pillar United States
Ronald N. Jones United States
M. Roussel‐Delvallez France
Citations per year, relative to Elisabeth Löwdin Elisabeth Löwdin (= 1×)
peers
Karen E. Bowker
Countries citing papers authored by Elisabeth Löwdin
Since
Specialization
Citations
This map shows the geographic impact of Elisabeth Löwdin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Löwdin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Löwdin more than expected).
Fields of papers citing papers by Elisabeth Löwdin
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Elisabeth Löwdin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Löwdin. The network helps show where Elisabeth Löwdin may publish in the future.
Co-authorship network of co-authors of Elisabeth Löwdin
This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Löwdin. A scholar is included among the top collaborators of Elisabeth Löwdin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Löwdin. Elisabeth Löwdin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kurland, Siri, Mia Furebring, Elisabeth Löwdin, Lars Olaison, & Jan Sjölin. (2025). Antifungal Therapy in Candida Infective Endocarditis: A Comparison of Echinocandins and Other Treatment Regimens in a Nationwide Cohort Study. Clinical Infectious Diseases. 82(3). e455–e461.
2.
Kurland, Siri, Elisabeth Löwdin, Mia Furebring, et al.. (2021). Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?. Mycoses. 65(1). 79–87.
3.
Tängdén, Thomas, et al.. (2013). Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. Journal of Antimicrobial Chemotherapy. 68(6). 1319–1326.
4.
Löwdin, Elisabeth, et al.. (2011). Voriconazole-Induced Inhibition of the Fungicidal Activity of Amphotericin B in Candida Strains with Reduced Susceptibility to Voriconazole: an Effect Not Predicted by the MIC Value Alone. Antimicrobial Agents and Chemotherapy. 55(4). 1629–1637.
5.
Lignell, Antti, Elisabeth Löwdin, Otto Cars, & Jan Sjölin. (2008). Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model. Journal of Antimicrobial Chemotherapy. 62(1). 142–148.
6.
Tano, Eva, et al.. (2007). Propensity to release endotoxin after two repeated doses of cefuroxime in an in vitro kinetic model: higher release after the second dose. Journal of Antimicrobial Chemotherapy. 60(2). 328–333.
7.
Lignell, Antti, Anders Johansson, Elisabeth Löwdin, Otto Cars, & Jan Sjölin. (2007). A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole. Clinical Microbiology and Infection. 13(6). 613–619.
8.
Nielsen, Elisabet I., Anders Viberg, Elisabeth Löwdin, et al.. (2006). Semimechanistic Pharmacokinetic/Pharmacodynamic Model for Assessment of Activity of Antibacterial Agents from Time-Kill Curve Experiments. Antimicrobial Agents and Chemotherapy. 51(1). 128–136.
9.
Tano, Eva, Otto Cars, & Elisabeth Löwdin. (2005). Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model. Journal of Antimicrobial Chemotherapy. 56(1). 240–242.
10.
Odenholt, Inga, Otto Cars, & Elisabeth Löwdin. (2004). Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens. Journal of Antimicrobial Chemotherapy. 54(6). 1062–1066.
11.
Odenholt, Inga, Elisabeth Löwdin, & Otto Cars. (2003). In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium. Clinical Microbiology and Infection. 9(9). 930–937.
12.
Odenholt, Inga, Ingegerd Gustafsson, Elisabeth Löwdin, & Otto Cars. (2003). Suboptimal Antibiotic Dosage as a Risk Factor for Selection of Penicillin-Resistant Streptococcus pneumoniae : In Vitro Kinetic Model. Antimicrobial Agents and Chemotherapy. 47(2). 518–523.
13.
Odenholt, Inga, Elisabeth Löwdin, Ingegerd Gustafsson, & Otto Cars. (2002). Pharmacodynamics of Moxifloxacin against Streptococcus pyogenes in an In Vitro Kinetic Model. Antimicrobial Agents and Chemotherapy. 46(6). 2046–2048.
14.
Löwdin, Elisabeth, Otto Cars, & Inga Odenholt. (2002). Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens including a pharmacokinetically enhanced formulation. Clinical Microbiology and Infection. 8(10). 646–653.
15.
Odenholt, Inga, Elisabeth Löwdin, & Otto Cars. (1998). Bactericidal effects of levofloxacin in comparison with those of ciprofloxacin and sparfloxacin. Clinical Microbiology and Infection. 4(5). 264–270.
16.
Odenholt, Inga, Elisabeth Löwdin, & Otto Cars. (1998). In Vitro Pharmacodynamic Studies of L-749,345 in Comparison with Imipenem and Ceftriaxone against Gram-Positive and Gram-Negative Bacteria. Antimicrobial Agents and Chemotherapy. 42(9). 2365–2370.
17.
Löwdin, Elisabeth, Inga Odenholt, & Otto Cars. (1998). In Vitro Studies of Pharmacodynamic Properties of Vancomycin against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy. 42(10). 2739–2744.
18.
Odenholt, Inga, Elisabeth Löwdin, & Otto Cars. (1997). Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria. Clinical Microbiology and Infection. 3(1). 73–81.
19.
Löwdin, Elisabeth, Inga Odenholt, Stellan Bengtsson, & Otto Cars. (1996). Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model. Antimicrobial Agents and Chemotherapy. 40(11). 2478–2482.
20.
Odenholt-Tornqvist, Inga, Elisabeth Löwdin, & Otto Cars. (1995). Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. Antimicrobial Agents and Chemotherapy. 39(1). 221–226.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Karen E. Bowker Breakdown of academic impact, for papers by Marie-Dominique Kitzis Breakdown of academic impact, for papers by Ronald N. Jones Breakdown of academic impact, for papers by Wenchi Shang Breakdown of academic impact, for papers by Michael Kresken Breakdown of academic impact, for papers by Jane E. Ambler Breakdown of academic impact, for papers by C J Soussy Breakdown of academic impact, for papers by Chris M. Pillar Breakdown of academic impact, for papers by Ronald N. Jones Breakdown of academic impact, for papers by M. Roussel‐Delvallez